Read about our potential breakthrough in oncology - restoring wild type p53 function with ASTX295. This molecule was co-developed with Astex Pharmaceuticals, and is currently showing great phase I trial readout! #cancer #medchem #clinicaltrials
www.linkedin.com/posts/cancer...
2024 milestones worth celebrating 🧬🌟
Bravo to the incredible researchers at the Drug Discovery Unit at Newcastle University. They've unlocked a potential…
